ESC Premium Access

There is no sweet spot in diabetes

Event: ESC Congress 2018
Topic: Comorbidities
Session type: Rapid Fire Abstracts
Date: 26 August 2018
Time: 16:45 - 17:45

Session

6 presentations in this session

Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus - The MET-REMODEL trialM

Speaker: Professor C. Lang (Dundee, GB)
Thumbnail

Association between insulin resistance and coronary plaque vulnerability in patients with acute coronary syndromes: insights from optical coherence tomography

Speaker: Doctor S. Wu (Beijing, CN)
Thumbnail

Impact of statin treatment on the prevalence of lesion vulnerability and instability features in patients with diabetes mellitus - Insights from the COMBINE (FFR-OCT) Study

Speaker: Doctor B. Berta (Kecskemet, HU)
Thumbnail

Sex differences in mortality and rates of cardiovascular disease in patients with diabetes

Speaker: Mr M. Malmborg (Copenhagen, DK)
Thumbnail

Impact of diabetes on 5-year clinical outcomes in stable coronary artery disease, across multiple geographical regions and ethnicities. Insights from the CLARIFY registry

Speaker: Doctor K. Mak (Singapore, SG)
Thumbnail

Impact of chronic kidney disease on diabetic patients with stable coronary disease undergoing surgery, angioplasty or medical treatment in a ten-year follow-up.

Speaker: Mr E. Martins (Sao Paulo, BR)
Thumbnail

6 speakers from this session

Professor Chim Choy Lang

University of Dundee, Dundee (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor Sijing Wu

Beijing Anzhen Hospital, Beijing (China)
0 follower

Doctor Balazs Berta

Bacs-Kiskun Hospital, Kecskemet (Hungary)
0 follower

Mr Morten Malmborg

The Danish Heart Foundation, Copenhagen (Denmark)
0 follower

Doctor Koon-Hou Mak

Mak Heart Clinic, Singapore (Singapore)
0 follower

Mr Eduardo Martins

University of Sao Paulo, Sao Paulo (Brazil)
0 follower

This platform is supported by

logo Novo Nordisk